PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
9,074,781
Share change
+235,626
Total reported value
$7,595,095
Put/Call ratio
126%
Price per share
$0.84
Number of holders
34
Value change
-$752,497
Number of buys
17
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q2 2017

As of 30 Jun 2017, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,074,781 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, FEDERATED INVESTORS INC /PA/, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Virtu KCG Holdings LLC, OxFORD Asset Management LLP, A.R.T. Advisors, LLC, UBS Group AG, DEUTSCHE BANK AG\, UBS OCONNOR LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.